There are early signs that cocaine use and availability is on the rise in the United States for the first time in almost a decade, according to a new State Department report on the global narcotics trade. The increase may be due to an expansion in Colombia’s coca crop, according to The Washington Post.
A hospital in New Haven, Connecticut treated 12 people who overdosed last June when they used fentanyl that had been sold as cocaine, according to the Centers for Disease Control and Prevention. Three of the people died.
A new study suggests restrictions put into place by the U.S. government on a chemical needed to produce cocaine have led to a reduced use of the drug in the past decade. Mexican police action against a company importing pseudoephedrine, which is used to make meth, also contributed to the decline.
Two anti-cocaine efforts in Colombia, funded by American taxpayers, were not cost-effective, according to an analysis by two economists. The interventions “are inefficient and socially costly ways of reducing drug consumption,” they conclude.